MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0025474
Medicone Formulations Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.74 Cr
▲ 6% YoY
Net profit · FY 2024
₹14.8 Lakh
Net margin 8.5%
EBITDA · FY 2024
₹26.44 Lakh
EBITDA margin 15.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹79 Lakh
Secured borrowings
Company age
25 yrs
Est. 2001
Directors on board
3
As per MCA filings
About Medicone Formulations Private Limited
Data last updated:
Medicone Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 22 February 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2001PTC109768. Its GSTIN is 09AADCM7323E1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sankalp Bansal and Seema Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J – 12/71 – A Ist Floor Rajouri Garden, New Delhi, Delhi, India – 110027.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.74 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹14.8 Lakh (net margin 8.5%) and EBITDA of ₹26.44 Lakh (EBITDA margin 15.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹79 Lakh on record.
Medicone Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0025474). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mediconegroup.com.
Company details
CIN U24231DL2001PTC109768
Registration Number 109768
Incorporation Date 22 February 2001
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0025474
Recognitions & Rankings of Medicone Formulations
Contact details
Medicone Formulations Private Limited's registered office is in New Delhi, Delhi. Its website is mediconegroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressJ – 12/71 – A Ist Floor Rajouri Garden, New Delhi, Delhi, India – 110027
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Medicone Formulations Private Limited, buy the company report.
Comprehensive company report
Medicone Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medicone Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medicone Formulations Private Limited, buy the company report.
Financials of Medicone Formulations Private Limited
FY 2025 filings availableMedicone Formulations Private Limited reported revenue of ₹1.74 Cr (up 6% YoY) for FY 2024.
Revenue · FY 2024
₹1.74 Cr ▲ 6%
Net profit · FY 2024
₹14.8 Lakh margin 8.5%
EBITDA · FY 2024
₹26.44 Lakh margin 15.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 12%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 57%
5 years · compounded
▲ 26%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | ||||
| Net Profit Margin | 8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicone Formulations Private Limited, buy the company report.
Board of directors of Medicone Formulations Private Limited
Medicone Formulations has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sankalp Bansal | Director | 30 Jun 2005 | 21 Years 3 Months | Current |
| Seema Bansal Also directs: Innthink Technologies Private Limited | Director | 30 Jun 2009 | 17 Years 3 Months | Current |
| Nalin Kumar Bansal Also directs: Innthink Technologies Private Limited | Director | 22 Feb 2001 | 25 Years 8 Months | Current |
Peer comparison
Medicone Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medicone Formulations Private Limitedthis company | ₹1.74 Cr (FY 2024) | ₹14.8 Lakh | 8.5% | 6.0% | New Delhi, Delhi, India | |
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Rex Medicare Private Limited | ₹1.73 Cr (FY 2025) | -1.0% | Ahmedabad, Gujarat, India | |||
| Nexba Healthcare Marketing & Services Private Limited | ₹1.73 Cr (FY 2025) | 34.0% | Kanayannur, Kerala, India |
To see the full peer comparison of Medicone Formulations Private Limited, buy the company report.
Auditor
Medicone Formulations Private Limited is audited by ANUJ GOYAL AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUJ GOYAL AND CO | FY 2023 | 004881C |
Shareholding
The shareholding of Medicone Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medicone Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹79 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2021 | 100487933 | Axis Bank Limited | ₹35 Lakh | Open | |
| 13 Sep 2021 | 100476764 | Others | ₹34 Lakh | Open | |
| 14 Feb 2011 | 10271271 | Punjab & Sind Bank | ₹10 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Medicone Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Medicone Formulations Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| East African (India) Overseas |
To see the full MSME payment records of Medicone Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medicone Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCM7323E1ZL | Uttar Pradesh | Active | 02 Aug 2017 |
To see the full GST registrations and return filing status of Medicone Formulations Private Limited, buy the company report.
Recent activity
Medicone Formulations Private Limited has 5 board changes on record since 2001: 3 appointments and 2 cessations. The latest: Gaurav Bhargava ceased to be Director on 30 Jun 2009.
AGM
Medicone Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicone Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 100487933 was registered on 30 Sep 2021.
Charges
A charge with Others amounted to Rs. 34.00 Lakh with Charge ID 100476764 was registered on 13 Sep 2021.
Charges
A charge with Punjab & Sind Bank amounted to Rs. 10.00 Lakh with Charge ID 10271271 was registered on 14 Feb 2011.
Ceased
Gaurav Bhargava ceased to be Director.
Appointed
Seema Bansal was appointed as Director.
Ceased
Sunil Bhargava ceased to be Director.
Appointed
Sankalp Bansal was appointed as Director.
Appointed
Nalin Kumar Bansal was appointed as Director.
Incorporation
22 Feb 2001
Medicone Formulations Private Limited was registered on 22 Feb 2001 with Roc Delhi & aged 25 years 8 months as per MCA records.
Frequently asked questions
Medicone Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 22 February 2001 (25+ years old) and is registered under CIN U24231DL2001PTC109768.
Medicone Formulations has 3 current directors:
- Sankalp Bansal - Director
- Seema Bansal - Director
- Nalin Kumar Bansal - Director
The latest financial statements of Medicone Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medicone Formulations is 09AADCM7323E1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medicone Formulations is U24231DL2001PTC109768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicone Formulations was incorporated on 22 February 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medicone Formulations by revenue are Sandmartin Pharmaceuticals Private Limited, Rex Medicare Private Limited, Nexba Healthcare Marketing & Services Private Limited, all in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Gaurav Bhargava ceased to be Director on 30 Jun 2009. Seema Bansal was appointed as Director on 30 Jun 2009. Sunil Bhargava ceased to be Director on 30 Jun 2009. Medicone Formulations has 5 board changes on record in total.
Yes, Medicone Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0025474).
Medicone Formulations has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.
Medicone Formulations can be reached through the website mediconegroup.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Medicone Formulations is at J – 1271 – A Ist Floor Rajouri Garden, New Delhi, Delhi, India – 110027.